This was the stock's second consecutive day of losses.

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither ...

Elevance Health trades at $423.06 per share and has stayed right on track with the overall market, losing 14% over the last ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 15 years ago, it would be worth $667.52 today based on a ...

This compares to the stock's 8% gain over the past four weeks. Elevance Health’s share price benefited from investors seeking stability amid heightened market volatility. A sharp sell-off in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bernstein raised the firm’s price target on Elevance Health (ELV) to $585 from $511 and keeps an Outperform rating on the shares. The firm sees ...

Truist Financial analyst Richard Newitter reiterated a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of ...